These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 14466528)

  • 21. Development of resistance to folic acid antagonists in a transplantable lymphoid leukemia.
    LAW LW; BOYLE PJ
    Proc Soc Exp Biol Med; 1950 Jul; 74(3):599-602. PubMed ID: 15440903
    [No Abstract]   [Full Text] [Related]  

  • 22. In vitro conversion of pteroylglutamic acid to citrovorum factor by rat liver enzymes.
    NORONHA JM; SREENIVASAN A
    Biochim Biophys Acta; 1960 Oct; 44():64-71. PubMed ID: 13729587
    [No Abstract]   [Full Text] [Related]  

  • 23. A new enzymic reaction concerned in the metabolism of beta-hydroxyglutamic acid.
    KURATOMI K; FUKUNAGA K
    Biochim Biophys Acta; 1960 Oct; 43():562-3. PubMed ID: 13755256
    [No Abstract]   [Full Text] [Related]  

  • 24. The physiological disposition of dichloromethotrexate-C136 in animals.
    OLIVERIO VT; DAVIDSON JD
    J Pharmacol Exp Ther; 1962 Jul; 137():76-83. PubMed ID: 14481833
    [No Abstract]   [Full Text] [Related]  

  • 25. Influence of folic acid on xanthine oxidation in vitro.
    FATTERPAKER P; SREENIVASAN A
    Nature; 1951 Jan; 167(4239):149-50. PubMed ID: 14806403
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of different dose schedules of amethopterin on serum and tissue concentrations and urinary excretion patterns.
    LIGUORI VR; GIGLIO JJ; MILLER E; SULLIVAN RD
    Clin Pharmacol Ther; 1962; 3():34-40. PubMed ID: 14465252
    [No Abstract]   [Full Text] [Related]  

  • 27. [Inhibitors of folic acid metabolism (author's transl)].
    Drews J
    Infection; 1980; 8 Suppl 3():S 268-75. PubMed ID: 6997204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. THE BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ACTION AND EFFECTS OF THE FOLIC ACID ANTAGONISTS.
    WERKHEISER WC
    Cancer Res; 1963 Sep; 23():1277-85. PubMed ID: 14070382
    [No Abstract]   [Full Text] [Related]  

  • 29. FOLIC ACID ANTAGONIST. EFFECTS ON THE CELL AND THE PATIENT. COMBINED CLINICAL STAFF CONFERENCE AT THE NATIONAL INSTITUTES OF HEALTH.
    BERLIN NI; RALL D; MEAD JA; FREIREICH EJ; VANSCOTT E; HERTZ R; LIPSETT MB
    Ann Intern Med; 1963 Dec; 59():931-56. PubMed ID: 14082744
    [No Abstract]   [Full Text] [Related]  

  • 30. On the enzymic reduction of folic acid by a purified hydrogenase.
    ZAKRZEWSKI SF; NICHOL CA
    Biochim Biophys Acta; 1958 Feb; 27(2):425-6. PubMed ID: 13522752
    [No Abstract]   [Full Text] [Related]  

  • 31. [Research on monocarbon compounds. III. Research on the mechanism of tetrahydrofolate formylase].
    JAENICKE L; BRODE E
    Biochem Z; 1961; 334():342-56. PubMed ID: 13789142
    [No Abstract]   [Full Text] [Related]  

  • 32. The enzymic destruction of carotenoids by isolated chloroplasts.
    FRIEND J; MAYER AM
    Biochim Biophys Acta; 1960 Jul; 41():422-9. PubMed ID: 13825192
    [No Abstract]   [Full Text] [Related]  

  • 33. The enzymic oxidation of o-aminophenols.
    NAGASAWA HT; MORGAN MA; GUTMANN HR
    Biochim Biophys Acta; 1958 Jun; 28(3):665-6. PubMed ID: 13560436
    [No Abstract]   [Full Text] [Related]  

  • 34. Antifolate metabolism and sites of action: implications for the design of new antifolates.
    Fitzhugh AL; Chabner BA; Sholar PW; Baram J; Allegra CJ
    NCI Monogr; 1987; (5):153-7. PubMed ID: 3431590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapeutic news--III. Folic coenzymes (folinic acid)].
    Minerva Med; 1984 May; 75(20):1247-54. PubMed ID: 6610137
    [No Abstract]   [Full Text] [Related]  

  • 36. The enzymic dephosphorylation and oxidation of psilocybin and psilocin by mammalian tissue homogenates.
    HORITA A; WEBER LJ
    Biochem Pharmacol; 1961 Jul; 7():47-54. PubMed ID: 13715852
    [No Abstract]   [Full Text] [Related]  

  • 37. Symposium on immunosuppressive drugs. Folate antagonists: some biochemical and pharmacological considerations.
    Bertino JR; Hillcoat BL; Johns DG
    Fed Proc; 1967; 26(3):893-7. PubMed ID: 5337985
    [No Abstract]   [Full Text] [Related]  

  • 38. [Distribution of folic acid antagonist, S35-labeled tomisine, in the body of rats].
    Korolev GK; Safonova TS; Singin AS; Vazilo VE; Iadrovskaia VA
    Med Radiol (Mosk); 1977 Sep; 22(9):45-52. PubMed ID: 927072
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacokinetics of aryldihydro-s-triazines with antifolate activity I: metabolism and excretion by rats.
    Ryan AJ; Ashley JJ; Upton RA
    J Pharm Sci; 1978 Mar; 67(3):306-9. PubMed ID: 641712
    [No Abstract]   [Full Text] [Related]  

  • 40. Stereochemical characteristics of the folate-antifolate transport mechanism in L1210 Leukemia cells.
    Sirotnak FM; Donsbach RC
    Cancer Res; 1974 Feb; 34(2):371-7. PubMed ID: 4855750
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.